The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Metformin Aurobindo 500 mg film-coated tablets

Aurobindo Pharma (Malta) LimitedPA1445/021/001

Main Information

Trade NameMetformin Aurobindo 500 mg film-coated tablets
Active SubstancesMetformin Hydrochloride
Dosage FormFilm-coated tablet
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/021/001

Group Information

ATC CodeA10BA Biguanides
A10BA02 metformin


License statusAuthorised
Licence Issued03/04/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0067-117-003
Interchangeable List DocumentPDF of Interchangeable List
« Back